UPDATE: Alliance Global Partners Downgrades T2 Biosystems (TTOO) to Neutral

January 27, 2021 8:21 AM EST
Get Alerts TTWO Hot Sheet
Price: $171.88 -1.35%

Rating Summary:
    26 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 9 | New: 25
Trade Now! 
Join SI Premium – FREE

(Updated - January 27, 2021 8:44 AM EST)

Alliance Global Partners analyst Ben Haynor downgraded T2 Biosystems (NASDAQ: TTOO) from Buy to Neutral with a $2.40 price target.

The analyst comments "The company announced preliminary unaudited Q4 revenue of $7.8 million, including $5.8 million in product revenue. For full year 2020, revenue came in at $18.1 million, below management's $19.0-$20.0 million guidance for the year. For Q4, we had modeled total revenue of $9.3 million including $7.8 million in product revenue. Our model was informed by management's guidance on the company's Q3 conference call where they raised the bottom end of their 2020 revenue guidance range by $1.0 million. However, the increase was driven by a revised expectation of research contribution revenue of $6.0 million, up from their prior guide of $5.0-$6.0 million. We would highlight T2's research contribution revenue came in at $6.5 million for the year, above our $6.0 million estimate."

For an analyst ratings summary and ratings history on Take-Two Interactive click here. For more ratings news on Take-Two Interactive click here.

Shares of Take-Two Interactive closed at $199.78 yesterday.

You May Also Be Interested In

Related Categories

Analyst Comments, Downgrades